Connect with us

Hi, what are you looking for?

News

Week In Review: Two China Biopharmas Announce Billion Dollar Deals

Deals and Financings

Suzhou MediLink Therapeutics out-licensed global rights (ex-China) for its antibody-drug conjugate candidate against Human Epidermal Growth Factor Receptor 3 (HER3) to BioNTech (BNTX) in a $1.1 billion agreement (see story

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Ventas, Inc. (NYSE:VTR) Q2 2025 Earnings Conference Call July 31, 2025 10:00 AM ET Company Participants Bill Grant – Senior Vice President of Investor...

Videos

Watch full video on YouTube